Cocoa Polyphenols and Postprandial Metabolism in Type 2 Diabetes
Completed · Not applicable · Has a placebo group
Conditions studied: Type 2 Diabetes
In brief
This study aims to investigate the postprandial effects of cocoa supplementation in glucose and lipids, and surrogate markers of atherosclerosis in patients with type 2 diabetes. The investigators aim to test the hypothesis that cocoa will lower high-fat mixed meal breakfast-induced postprandial rise of glucose, lipids and markers of atherosclerosis in patients with diabetes. Randomized cross-over controlled trial, in which participants will be assigned to the placebo or cocoa group with breakfast meal. Patients with type 2 diabetes(n=25) will qualify for the study. The participants will be asked to consume 2 cups cocoa or placebo beverage on 2 separate postprandial study days. Both groups will receive high-fat mixed meal breakfast on each day. Blood draws and blood pressure (including HDI) measurements will be conducted at fasting, 30 min, 1,2, 4 \& 6 hours postprandial each day for 2 days.
Key facts
- Study ID
- NCT01886989
- Run by
- Arpita Basu
- People needed
- 18
- Starts
- 2012-01-01
- Expected to finish
- 2014-12-01
- Last updated by the study team
- 2018-01-23
Who can join
Age: 21 and older, up to 60. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- clinical diagnosis of type 2diabetes
You may not qualify if…
- on insulin therapy
Where it is running
- Department of Nutritional Sciences — Stillwater, Oklahoma, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.